Harms from haloperidol for symptom management in palliative care; a post hoc pooled analysis of three randomized controlled studies and two consecutive cohort studies

Symptom control for people with cancer improves quality of life. Haloperidol is a key drug in palliative care and is frequently used for the treatment of delirium, nausea and vomiting.[1] Haloperidol, a butyrophenone, is a more potent D2 receptor antagonist than other antiemetics such as prochlorperazine, olanzapine or chlorpromazine.

Source: Journal of Pain and Symptom Management - May 19, 2019 Category: Palliative Care Authors: Hiromichi Matsuoka, Meera Agar, Zac Vandersman, Phillip Good, Belinda Fazekas, Linda Brown, Hardy Janet, Jennifer Weil, D.C. Currow Source Type: research